Global Ion Channel Modulators Market Report 2021: Analytics 2012-2019 & Trajectory 2020-2027 – Market to Reach $13.9 Billion by 2027 – ResearchAndMarkets.com

Global Ion Channel Modulators Market Report 2021: Analytics 2012-2019 & Trajectory 2020-2027 – Market to Reach $13.9 Billion by 2027 – ResearchAndMarkets.com




Global Ion Channel Modulators Market Report 2021: Analytics 2012-2019 & Trajectory 2020-2027 – Market to Reach $13.9 Billion by 2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Ion Channel Modulators – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Global Ion Channel Modulators Market to Reach $13.9 Billion by 2027

Amid the COVID-19 crisis, the global market for Ion Channel Modulators estimated at US$11.1 Billion in the year 2020, is projected to reach a revised size of US$13.9 Billion by 2027, growing at a CAGR of 3.3% over the period 2020-2027.

Channel Blockers, one of the segments analyzed in the report, is projected to record 3.6% CAGR and reach US$9.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Channel Openers segment is readjusted to a revised 2.6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $3.3 Billion, While China is Forecast to Grow at 3.1% CAGR

The Ion Channel Modulators market in the U.S. is estimated at US$3.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2027 trailing a CAGR of 3.1% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.1% and 2.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS (Total 39 Featured):

  • Abcam plc
  • Ablynx NV
  • Airmid Inc.
  • Akashi Therapeutics Inc.
  • Alion Pharmaceuticals Inc.
  • Allergan plc
  • AstraZeneca PLC
  • Aurora Biomed Inc.
  • Autifony Therapeutics Limited
  • Axxam S.p.A.
  • Bayer AG
  • Pharmaceuticals
  • Biogen Inc.
  • Bio-Techne Corporation
  • CalciMedica Inc.
  • Charles River Laboratories International Inc.

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • United States
  • Canada
  • Japan
  • China
  • Europe
  • France
  • Germany
  • Italy
  • United Kingdom
  • Spain
  • Russia
  • Rest of Europe
  • Asia-Pacific
  • Australia
  • India
  • South Korea
  • Rest Of Asia-Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East
  • Iran
  • Israel
  • Saudi Arabia
  • United Arab Emirates
  • Rest of Middle East
  • Africa

IV. COMPETITION

  • Total Companies Profiled: 39

For more information about this report visit https://www.researchandmarkets.com/r/lxo661

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900